GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (TSE:4528) » Definitions » Other Operating Expense

Ono Pharmaceutical Co (TSE:4528) Other Operating Expense : 円3,636 Mil (TTM As of Mar. 2025)


View and export this data going back to 1963. Start your Free Trial

What is Ono Pharmaceutical Co Other Operating Expense?

Ono Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2025 was 円3,352 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was 円3,636 Mil.

Ono Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2024 (円-216 Mil) to Dec. 2024 (円-72 Mil) and increased from Dec. 2024 (円-72 Mil) to Mar. 2025 (円3,352 Mil).

Ono Pharmaceutical Co's annual Other Operating Expense declined from Mar. 2023 (円10,331 Mil) to Mar. 2024 (円3,167 Mil) but then increased from Mar. 2024 (円3,167 Mil) to Mar. 2025 (円3,636 Mil).


Ono Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Ono Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Other Operating Expense Chart

Ono Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,233.00 11,718.00 10,331.00 3,167.00 3,636.00

Ono Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,139.00 572.00 -216.00 -72.00 3,352.00

Ono Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,636 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ono Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Ono Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a world-wide business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co Headlines

No Headlines